ãã¥ãŒãã¯ã©ã€ã³ ãã€ãªãµã€ãšã³ã·ãºã¯ãç¥çµç§åŠã«éç¹ã眮ãããã€ãªå»è¬åäŒæ¥ã§ãããç¥çµçŸæ£ãå
åæ³çŸæ£ã粟ç¥çŸæ£ã®æ£è
ã®ããã®ããŸããŸãªæ²»çæ³ãçºèŠãéçºãæäŸããŠããŸããå瀟ã®ããŒããã©ãªãªã«ã¯ãé
çºæ§ãžã¹ãããžã¢ãããŒãã³ãœã³ç
ãåå®®å
èçãåå®®çè
«ã®æ²»çè¬ã®ã»ããããŸããŸãªæ²»çé åã®èšåºããã°ã©ã ãå«ãŸããŠããŸããäž»å補åã¯ãé
çºæ§ãžã¹ãããžã¢ã®æ²»çè¬ã§ãã VMAT2 é»å®³å€ã® INGREZZA ã§ããå瀟ã®è£œåã«ã¯ãããŒãã³ãœã³ç
æ£è
ã«å¯Ÿããã¬ããã/DOPA è±çé
žé
µçŽ é»å®³å€ã®è£å©çæ³ãšããŠäœ¿çšãããã«ãã³ãŒã«-O-ã¡ãã«ãã©ã³ã¹ãã§ã©ãŒãŒé»å®³å€ã® ONGENTYSã女æ§ã®äžç床ããé床ã®åå®®å
èçã®çã¿ã®ç®¡çã«äœ¿çšããã ORILISSA ããããŸãããŸããéçµå女æ§ã®åå®®çè
«ã«äŒŽãæçµéå€ã®ç®¡çãç®çãšããéå€ç§ççµå£è¬ORIAHNNãéçºäžã§ãããèšåºéçºäžã®è£œååè£ã«ã¯ãå°å
æ£è
ããã³æäººã®éšåæ§ãŠãããã®é©å¿çãæ²»çããããã®NBI-921352ãå°å
ã®çšãªãŠãããããã³ãã®ä»ã®é©å¿çãæ²»çããããã®NBI-827104ãããã³ã¯ãªãã»ã«ãã©ã³ãããããèšåºéçºäžã®å瀟ã®è£œåã«ã¯ãçµ±å倱調çã®é°æ§çç¶ã®æ²»çã®ããã®NBI-1065844ãæ²»çæµææ§ãã€ç
ã®æ²»çã®ããã®NBI-1065845ããã€ç
ã«ãããç¡å¿«æçã®æ²»çã®ããã®NBI-1065846ããããå瀟ã¯ãæŠç°è¬åå·¥æ¥æ ªåŒäŒç€ŸãIdorsia Pharmaceuticals LtdãXenon Pharmaceuticals Inc.ãVoyager Therapeutics, Inc.ãBIAL ? Portela & Ca, SAãç°èŸºäžè±è£œè¬æ ªåŒäŒç€Ÿãããã³ç±³åœããã³ãã®ä»ã®åœã
ãšã©ã€ã»ã³ã¹ããã³ååå¥çŽãçµãã§ããã AbbVie Inc.ãSentia Medical Sciences Inc. ãªã©ã§ããNeurocrine Biosciences, Inc. 㯠1992 幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãµã³ãã£ãšãŽã«æ¬ç€Ÿã眮ããŠããŸãã